OR
Pharmacy Tours Highlight Vital Need for DIR Fee Relief
The total number of NACDS RxIMPACT 2019 in-district events to promote DIR relief priorities now stands at 72—and counting.
Get Ready for NACDS TSE—August 24-26 in Boston
Get a step ahead to make the most of your time at the upcoming NACDS Total Store Expo—August 24-26 in Boston.
Pharmacy Urges Decisive Action to Close DIR Fee Loophole, Appreciates Senate Finance Committee’s Initial Bipartisan Movement on Issue “DIR relief means closing the loophole that is over-charging seniors and Medicare and making it unsustainable for pharmacies. DIR relief is essential for any drug-pricing legislation”
“DIR relief means closing the loophole that is over-charging seniors and Medicare and making it unsustainable for pharmacies. DIR relief is essential for any drug-pricing legislation”
DIR Fee Relief Urgency Clear at NACDS Board Member D.C. Fly-in
NACDS Board of Directors members met with key members of Congress in Washington, D.C., to convey the urgent need for DIR fee relief.
DIR Fee Relief Leads NACDS RxIMPACT Pharmacy Tours
Members of Congress were able to grasp firsthand critical pharmacy public policy issues when they toured pharmacies in their home states and congressional districts.
DEA ARCOS Data Release: NACDS Statement on Pharmacy’s Commitment as Part of the Solution to Opioid Abuse
NACDS President & CEO Steven C. Anderson, IOM, CAE, issued a statement regarding pharmacies' long-standing and ongoing commitment as part of the opioid-abuse solution.
DIR Fee Relief Urged in NACDS’ New Cable, Broadcast, Digital Ads NACDS: “Dire” problem for patients, pharmacies must be fixed in drug-pricing bill
NACDS: “Dire” problem for patients, pharmacies must be fixed in drug-pricing bill
NACDS Praises Missouri’s E-prescribing Law as Proactive Step in Opioid Abuse Prevention Sixty-two percent of Missouri voters support e-prescribing requirement as a fraud and abuse prevention strategy
Sixty-two percent of Missouri voters support e-prescribing requirement as a fraud and abuse prevention strategy.
Need for DIR Fee Relief Hits Home for Congress
During the Fourth of July congressional recess, members of Congress learned firsthand about key pharmacy issues—particularly about the need for direct and indirect remuneration (DIR) fee relief as part of a drug-pricing legislative package.
NACDS Commends Delaware’s E-prescribing Law as Critical Step in Opioid Abuse Prevention Sixty-four percent of Delaware voters support e-prescribing requirement as a fraud and abuse prevention strategy
Sixty-four percent of Delaware voters support e-prescribing requirement as a fraud and abuse prevention strategy.